-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Rapid response—delivered in one go! Shisi Pharmaceutical swiftly delivered 600,000 Abidol capsules to Wuhan.
Category:
Time：2020-02-22
The large truck tasked with the urgent transportation of 125 shipments—comprising 50,000 boxes and 600,000 capsules of abidol hydrochloride—of national epidemic prevention and control supplies from Shijiazhuang Sihua Pharmaceutical Co., Ltd. departed from Shijiazhuang at 4 p.m. on February 20. Traveling through the night and day, the truck arrived early in the morning of February 21 at the warehouse of Sinopharm Holding Hubei Company in Wuhan. From receiving the “national assignment” to delivering the emergency medication, Shijiazhuang Sihua Pharmaceutical took less than two days. ▲On the morning of February 21, the truck carrying 125 shipments—totaling 600,000 capsules of abidol hydrochloride—arrived at the warehouse of Sinopharm Holding Hubei Company in Wuhan, marking the successful delivery of the national emergency drug supply.
The large truck tasked with the urgent transportation of 125 shipments—comprising 50,000 boxes and 600,000 capsules of abidol hydrochloride—belonging to Shijiazhuang Sihua Pharmaceutical Co., Ltd., as part of the national epidemic prevention and control material security effort, departed from Shijiazhuang at 4 p.m. on February 20. Traveling through the night and day, it arrived early in the morning of February 21 at the warehouse of Sinopharm Holding Hubei Company in Wuhan. From receiving the “national assignment” to delivering the emergency medication, Shijiazhuang Sihua Pharmaceutical took less than two days.
▲On the morning of February 21, a truck carrying 125 cases—each containing 600,000 capsules—of abidol hydrochloride, a national emergency drug for epidemic prevention and control, arrived at the warehouse of Wuhan National Pharmaceutical Holdings Hubei Company, belonging to Shijiazhuang Fourth Pharmaceutical.
At 6 p.m. on February 19, Shijiazhuang No.4 Pharmaceutical received an “Emergency Task Dispatch Order” from the Medical Supplies Guarantee Group of the National Joint Prevention and Control Mechanism for the Novel Coronavirus Pneumonia Epidemic, requesting that the company overcome all difficulties to deliver, in batches, 50,000 boxes of Abidol Hydrochloride Capsules (12 capsules per box) to Hubei Province by February 26.
Upon receiving the “Emergency Task Dispatch Order,” Qu Jiguang, Chairman of the Board of Directors of Shisi Pharmaceutical Group, immediately stated that they would implement the task requirements to the letter and spare no effort in ensuring the supply of epidemic prevention materials for Hubei Province. Qu Jiguang said, “Supporting Hubei is a responsibility that our pharmaceutical company must fulfill. We must address Hubei’s urgent needs and the nation’s urgent needs, and deliver this batch of medicines to Hubei at the earliest possible moment.”
Zhu Zhiyong, Deputy General Manager of New Drug Marketing at Shijiazhuang Fourth Pharmaceutical Co., Ltd., immediately got in touch with Sinopharm Holding Hubei Company. Upon hearing that Shijiazhuang Fourth Pharmaceutical had arranged to deliver the entire stock of emergency drug Abidor capsules in one go, the contact person from Sinopharm Holding Hubei expressed repeated gratitude over the phone: “This is truly a timely help in times of need—Shijiazhuang Fourth Pharmaceutical, we can’t thank you enough!” The sales, finance, warehouse, and transportation departments coordinated closely and responded swiftly, quickly completing the outbound procedures.
▲On the morning of February 21, a truck carrying 125 cases—each containing 600,000 capsules—of abidol hydrochloride, a national emergency drug for epidemic prevention and control, arrived at the warehouse of Wuhan National Pharmaceutical Holdings Hubei Company, belonging to Shijiazhuang Fourth Pharmaceutical.
At 2:30 p.m. on February 20, we quickly organized the loading of the truck. At 4:00 p.m., the truck carrying 125 items—50,000 boxes containing a total of 600,000 abidol hydrochloride capsules—set off onto the Beijing-Hong Kong-Macao Expressway, speeding toward Wuhan. Just after 9:00 a.m. on February 21, Li Ligong, the manager of the Storage and Transportation Department responsible for the transportation and logistics support mission for Shijiazhuang Fourth Pharmaceutical, received a call from driver Deng Junpo: “We’ve arrived at our destination and are now completing the inbound procedures. We’ll be ready to unload the cargo shortly—please rest assured.”
Abidol Hydrochloride capsules are Shijiazhuang No.4 Pharmaceutical’s flagship antiviral product. From January 25 to February 20, Shijiazhuang No.4 Pharmaceutical had cumulatively supplied Hubei Province with 2.1 million Abidol Hydrochloride capsules, including 1.7 million capsules for Wuhan.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license